Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Clear Cell Adenocarcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Glandular Cell Neoplasm
Adenocarcinoma
Clear Cell Adenocarcinoma

Histology

Clear Cell Adenocarcinoma

CI-CAN-00002377Explore in graph →

150 active trials2 approved drugs19 evidence items

NCIt: C3766
MeSH: D018262

Overview
Statistics
Survival
Genomics12
Variants & evidence19
Drugs2
Trials362
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 150
Recruiting: 79
Ph III recruiting: 9
Growth YoY: −15.8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

StatusAll Active (any)Completed 122 Recruiting 86 Active Not Recruiting 57 Terminated 42 Unknown 21 Not Yet Recruiting 16 Withdrawn 13 Suspended 2 Enrolling By Invitation 2 No Longer Available 1

PhaseAll Early Phase 1 11 N/A 14 Phase 1 126 Phase 2 200 Phase 3 32

No study matches these filters